Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-06 · accession 0000950170-24-124113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-11-08 | 2024-11-06 | GMED | Scavilla Daniel T | Pres, CEO, Dir | S - Sale+OE | $80.02 | -60.0K | 0 | -100% | -$4.80M |
| DMT | 2024-11-08 | 2024-11-06 | GMED | Scavilla Daniel T | Pres, CEO, Dir | M - OptEx | $35.02 | +60.0K | 30.0K | New | +$2.10M |
| DMT | 2024-11-08 | 2024-11-06 | GMED | Scavilla Daniel T | Pres, CEO, Dir | M - OptEx | $0.00 | +60.0K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-06 | S | D | 60,000 | $80.02 | 0 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-11-06 | M | A | 30,000 | $43.77 | 60,000 | D | — | — | |
| 3 | Common | Class A Common Stock | 2024-11-06 | M | A | 30,000 | $26.27 | 30,000 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2024-11-06 | M | A | 30,000 | $0.00 | 50,000 | D | $43.77 · — to 2028-01-22 | 30,000 Class A Common Stock | (F3) These options were granted on January 22, 2018 and are fully vested. |
| 5 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2024-11-06 | M | A | 30,000 | $0.00 | 0 | D | $26.27 · — to 2027-01-30 | 30,000 Class A Common Stock | (F2) These options were granted on January 30, 2017 and are fully vested. |